Cargando…
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
BACKGROUND AND OBJECTIVE: With the rising importance of precision oncology in biliary tract cancer (BTC), the aim of this retrospective single-center analysis was to describe the clinical and molecular characteristics of patients with BTC who underwent comprehensive genomic profiling (CGP) and were...
Autores principales: | Zhang, Danmei, Dorman, Klara, Heinrich, Kathrin, Weiss, Lena, Boukovala, Myrto, Haas, Michael, Greif, Philipp A., Ziemann, Frank, Beyer, Georg, Roessler, Daniel, Goni, Elisabetta, Renz, Bernhard, D’Haese, Jan G., Kunz, Wolfgang G., Seidensticker, Max, Corradini, Stefanie, Niyazi, Maximilian, Ormanns, Steffen, Kumbrink, Jörg, Jung, Andreas, Mock, Andreas, Rudelius, Martina, Klauschen, Frederick, Werner, Jens, Mayerle, Julia, von Bergwelt-Baildon, Michael, Boeck, Stefan, Heinemann, Volker, Westphalen, C. Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517894/ https://www.ncbi.nlm.nih.gov/pubmed/37594677 http://dx.doi.org/10.1007/s11523-023-00985-3 |
Ejemplares similares
-
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich(LMU) Molecular Tumor Board
por: Dorman, Klara, et al.
Publicado: (2023) -
Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective
por: Weiss, L., et al.
Publicado: (2023) -
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
por: Sultova, Elena, et al.
Publicado: (2020) -
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2020) -
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2021)